Business
Grace and Molecule.one to Transform Peptide Building Block Synthesis with AI and Automation
W. R. Grace & Co. (Grace), a Standard Industries company and leading global supplier of specialty chemicals and solutions that enable industries to enhance modern life, and Molecule.one, a global leader in chemical AI and high-throughput chemistry and winner of the Standard Industries Chemical Innovation Challenge, today announced a strategic, multi-year agreement to discover and deploy new, scalable ways to manufacture chemical compounds.
About this update from Standard Industries Limited
[{"type":"text","content":"The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients faster","length":201,"tagName":"p","attribs":{}},{"type":"text","content":"COLUMBIA, Md. and WARSAW, Poland, Dec. 8, 2025 /PRNewswire/ -- W. R. Grace & Co. (Grace), a Standard Industries company and leading global supplier of specialty chemicals and solutions that enable industries to enhance modern life, and Molecule.one, a global leader in chemical AI and high-throughput chemistry and winner of the Standard Industries Chemical Innovation Challenge, today announced a strategic, multi-year agreement to discover and deploy new, scalable ways to manufacture chemical compounds.","length":515,"tagName":"p"},{"type":"image","alt":"Grace Molecule.one","displaySize":"","headline":null,"caption":"Grace Molecule.one","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":133,"url":"https://media.zenfs.com/en/prnewswire.com/21b7620fc3ccf4d8b14fc6dabea7d6c1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rC.fj8douXwUXkx2kMn5KA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIzNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/21b7620fc3ccf4d8b14fc6dabea7d6c1","width":400,"height":133}},"href":"https://mma.prnewswire.com/media/2840536/W_R_Grace__Grace_Molecule_one__logo_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"In the first phase of the collaboration, the companies will advance the synthesis of certain peptide building blocks using Molecule.one's MARIA™ platform for AI and high-throughput experimentation. Grace and Molecule.one are working together to address a supply chain bottleneck in peptide components—the building blocks essential for manufacturing therapeutics, including the rapidly expanding GLP-1 treatments for weight loss and diabetes. With strong demand for metabolic-disease peptides, the global market is expected to more than double by 2030, surpassing $100 billion and underscoring the urgent need for more efficient scaling and production.","length":655,"tagName":"p"},{"type":"text","content":""Combining Grace's deep expertise in fine chemicals with Molecule.one's award-winning AI and automation platform will allow us to transform the way we scale and ma...